Insider (James Budge) reports 17,693-share 10b5-1 sales

James Budge reported Rule 144 resale notices for sales executed under a 10b5-1 plan.

Rhea-AI Filing Summary

James Budge reported Rule 144 resale notices for sales executed under a 10b5-1 plan. The excerpt lists three completed sales: 11,006 shares on 03/23/2026 for $465,138.87, 5,906 shares on 05/11/2026 for $323,758.65, and 781 shares on 05/20/2026 for $43,220.54. It also lists 5,907 Restricted Stock Units dated 05/01/2026 as securities to be sold. Brokerage information names Morgan Stanley Smith Barney LLC.

Insights

Securities Compliance Counsel

Transactions are routine Rule 144 notices reporting 10b5-1 sales by a holder.

These entries record resale notices and completed 10b5-1 sales by James Budge with precise share counts and dollar amounts for three trade dates in 2026. The filing names Morgan Stanley Smith Barney LLC as the broker.

Timing and cash‑flow treatment are given as per‑trade proceeds; any broader impact depends on future disclosures in subsequent filings.

Key Figures

Total shares sold (listed): 17,693 shares Proceeds on 03/23/2026: $465,138.87 Proceeds on 05/11/2026: $323,758.65 +2 more

5 metrics

Total shares sold (listed) 17,693 shares Aggregate of three sale entries dated 03/23/2026, 05/11/2026, 05/20/2026

Proceeds on 03/23/2026 $465,138.87 11,006 shares sold on 03/23/2026

Proceeds on 05/11/2026 $323,758.65 5,906 shares sold on 05/11/2026

Proceeds on 05/20/2026 $43,220.54 781 shares sold on 05/20/2026

Restricted Stock Units listed 5,907 units Securities to be sold, dated 05/01/2026

Key Terms

10b5-1, Rule 144, Restricted Stock Units

3 terms

10b5-1 regulatory

"10b5-1 Sales for JAMES BUDGE 455 Market Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Rule 144 regulatory

"Form 144 resale notices and securities to be sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 05/01/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What trades did James Budge report for HNGE?

He reported three 10b5-1 sales: 11,006 shares on 03/23/2026 for $465,138.87, 5,906 shares on 05/11/2026 for $323,758.65, and 781 shares on 05/20/2026 for $43,220.54. Brokerage is listed as Morgan Stanley Smith Barney LLC.

What securities are listed as to be sold in the notice?

The notice lists 5,907 Restricted Stock Units dated 05/01/2026 as securities to be sold. The entry labels the instrument type as Restricted Stock Units and ties it to the issuer.

Were the sales executed under a trading plan?

Yes. Each completed sale is described as a 10b5-1 sale, indicating execution under a prearranged trading plan. The filing explicitly uses the phrase 10b5-1 Sales for each trade date in 2026.

Which broker is identified in the filing?

The filing names Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004 as the broker involved in the transactions.

Does the filing state who received the sale proceeds?

The excerpt shows dollar amounts for each trade (e.g., $465,138.87) but does not state a recipient beyond listing the selling holder and broker. Cash‑flow treatment beyond the trade entries is not specified in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:45 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001338176
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HINGE HEALTH INC
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES BUDGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5907	326361.75	54655926	05/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2026	Restricted Stock Units	Issuer			5907	05/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	05/20/2026	781	43220.54
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	05/11/2026	5906	323758.65
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	03/23/2026	11006	465138.87

144: Remarks and Signature

Remarks
Date of Notice	05/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Budge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)